Strengthening the Sustainability of the Off-Patent Antibiotic Supply Chain
February 15, 2023 – The AMR Industry Alliance today announced the publication of its report, “Strengthening the Sustainability of the Off-Patent Antibiotic Supply Chain,” which investigates the root causes of supply chain unsustainability among off-patent antimicrobials and identifies potential policy solutions to address these issues. The Alliance commissioned the report from Charles River Associates to analyze the factors that contribute to an unsustainable off-patent supply chain.
“The AMR Industry Alliance and its members are working to ensure that life-saving antimicrobials are available to patients worldwide,” said James Anderson, AMR Industry Alliance Board Chair. “To support this work, the Alliance and its members are committed to partnering with other stakeholders – including multinational organizations, governments, healthcare providers, and NGOs – to increase the sustainability of off-patent antimicrobial supply chains and reduce access barriers.”
The Alliance supports policies that improve supply chain sustainability and encourages its members and other stakeholders to consider the solutions listed below, which were identified as having high feasibility and potential impact:
- Pricing approaches to recognize the value of off-patent drugs;
- Better use of diagnostic and surveillance data;
- Sustainable tender policies requiring supply security and multiple winners; and
- Reducing financial disincentives to market entry;
To read the policy recommendations, click here. To read the full report, click here.